Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sanz-Moreno

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal Francais D'Ophtalmologie|June 8, 2013
[Hypotony maculopathy]N Padrón-Pérez, S Sanz-Moreno
Archivos De La Sociedad Espanola De Oftalmologia|December 10, 2002
[Bilateral neurotrophic keratitis secondary to encephalic trunk metastasis]N Ibáñez Flores, S Sanz Moreno
Journal Francais D'Ophtalmologie|February 26, 2013
["Vascular tufts"]S Sanz-Moreno, N Padrón-Pérez
Journal Francais D'Ophtalmologie|February 22, 2024
Ciliary body melanocytoma with anterior segment pigment dispersion and elevated intraocular pressureL Yamamoto-Rodríguez, S Sanz-Moreno, M J Paúles-Villar, et al.
ESMO Open|October 4, 2021
KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitorR Serna-Blasco, E Sánchez-Herrero, S Sanz-Moreno, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal Francais D'Ophtalmologie|June 8, 2013
[Hypotony maculopathy]N Padrón-Pérez, S Sanz-Moreno
Archivos De La Sociedad Espanola De Oftalmologia|December 10, 2002
[Bilateral neurotrophic keratitis secondary to encephalic trunk metastasis]N Ibáñez Flores, S Sanz Moreno
Journal Francais D'Ophtalmologie|February 26, 2013
["Vascular tufts"]S Sanz-Moreno, N Padrón-Pérez
Journal Francais D'Ophtalmologie|February 22, 2024
Ciliary body melanocytoma with anterior segment pigment dispersion and elevated intraocular pressureL Yamamoto-Rodríguez, S Sanz-Moreno, M J Paúles-Villar, et al.
ESMO Open|October 4, 2021
KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitorR Serna-Blasco, E Sánchez-Herrero, S Sanz-Moreno, et al.
Pageof 1